BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2103 related articles for article (PubMed ID: 24495527)

  • 1. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.
    Yoo JY; Kim SS
    Nutrients; 2016 Mar; 8(3):173. PubMed ID: 26999199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.
    Fallucca F; Porrata C; Fallucca S; Pianesi M
    Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():48-54. PubMed ID: 24532292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
    Brahe LK; Astrup A; Larsen LH
    Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
    West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
    J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and metabolic disorders: How prebiotic can work?
    Delzenne NM; Neyrinck AM; Cani PD
    Br J Nutr; 2013 Jan; 109 Suppl 2():S81-5. PubMed ID: 23360884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and prebiotics and health in ageing populations.
    Duncan SH; Flint HJ
    Maturitas; 2013 May; 75(1):44-50. PubMed ID: 23489554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods.
    Pushpass RG; Alzoufairi S; Jackson KG; Lovegrove JA
    Nutr Res Rev; 2022 Dec; 35(2):161-180. PubMed ID: 33926590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 106.